Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Nature ; 451(7174): 69-72, 2008 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-18172497

RESUMO

Mammalian homologues of Drosophila melanogaster transient receptor potential (TRP) are a large family of multimeric cation channels that act, or putatively act, as sensors of one or more chemical factor. Major research objectives are the identification of endogenous activators and the determination of cellular and tissue functions of these channels. Here we show the activation of TRPC5 (canonical TRP 5) homomultimeric and TRPC5-TRPC1 heteromultimeric channels by extracellular reduced thioredoxin, which acts by breaking a disulphide bridge in the predicted extracellular loop adjacent to the ion-selectivity filter of TRPC5. Thioredoxin is an endogenous redox protein with established intracellular functions, but it is also secreted and its extracellular targets are largely unknown. Particularly high extracellular concentrations of thioredoxin are apparent in rheumatoid arthritis, an inflammatory joint disease that disables millions of people worldwide. We show that TRPC5 and TRPC1 are expressed in secretory fibroblast-like synoviocytes from patients with rheumatoid arthritis, that endogenous TRPC5-TRPC1 channels of the cells are activated by reduced thioredoxin, and that blockade of the channels enhances secretory activity and prevents the suppression of secretion by thioredoxin. The data indicate the presence of a previously unrecognized ion-channel activation mechanism that couples extracellular thioredoxin to cell function.


Assuntos
Canais de Cátion TRPC/agonistas , Canais de Cátion TRPC/metabolismo , Tiorredoxinas/farmacologia , Animais , Artrite Reumatoide/metabolismo , Artrite Reumatoide/patologia , Linhagem Celular , Dissulfetos/química , Dissulfetos/metabolismo , Condutividade Elétrica , Humanos , Oxirredução/efeitos dos fármacos , Técnicas de Patch-Clamp , Coelhos , Canais de Cátion TRPC/química , Tiorredoxinas/química
2.
Mol Pharmacol ; 79(6): 1023-30, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21406603

RESUMO

The aim of this study was to generate new insight into chemical regulation of transient receptor potential (TRP) channels with relevance to glucose homeostasis and the metabolic syndrome. Human TRP melastatin 2 (TRPM2), TRPM3, and TRP canonical 5 (TRPC5) were conditionally overexpressed in human embryonic kidney 293 cells and studied by using calcium-measurement and patch-clamp techniques. Rosiglitazone and other peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists were investigated. TRPM2 was unaffected by rosiglitazone at concentrations up to 10 µM but was inhibited completely at higher concentrations (IC(50), ∼22.5 µM). TRPM3 was more potently inhibited, with effects occurring in a biphasic concentration-dependent manner such that there was approximately 20% inhibition at low concentrations (0.1-1 µM) and full inhibition at higher concentrations (IC(50), 5-10 µM). PPAR-γ antagonism by 2-chloro-5-nitrobenzanilide (GW9662) did not prevent inhibition of TRPM3 by rosiglitazone. TRPC5 was strongly stimulated by rosiglitazone at concentrations of ≥10 µM (EC(50), ∼30 µM). Effects on TRPM3 and TRPC5 occurred rapidly and reversibly. Troglitazone and pioglitazone inhibited TRPM3 (IC(50), 12 µM) but lacked effect on TRPC5, suggesting no relevance of PPAR-γ or the thiazolidinedione moiety to rosiglitazone stimulation of TRPC5. A rosiglitazone-related but nonthiazolidinedione PPAR-γ agonist, N-(2-benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-l-tyrosine (GW1929), was a weak stimulator of TRPM3 and TRPC5. The natural PPAR-γ agonist 15-deoxy prostaglandin J(2), had no effect on TRPM3 or TRPC5. The data suggest that rosiglitazone contains chemical moieties that rapidly, strongly, and differentially modulate TRP channels independently of PPAR-γ, potentially contributing to biological consequences of the agent and providing the basis for novel TRP channel pharmacology.


Assuntos
Canais de Cátion TRPC/efeitos dos fármacos , Canais de Cátion TRPM/efeitos dos fármacos , Tiazolidinedionas/farmacologia , Cálcio/metabolismo , Linhagem Celular , Humanos , Técnicas de Patch-Clamp , Rosiglitazona
3.
Cell Calcium ; 45(6): 583-8, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19324410

RESUMO

TRPC channels are a subset of the transient receptor potential (TRP) proteins widely expressed in mammalian cells. They are thought to be primarily involved in determining calcium or sodium entry and have broad-ranging functions that include regulation of cell proliferation, motility and contraction. The channels do not respond to a single stimulator but rather are activated or modulated by a multiplicity of factors, potentially existing as integrators at the plasma membrane. This review considers the sensitivity of TRPCs to lipid factors, with focus on sensitivities to diacylglycerols, lysophospholipids, arachidonic acid and its metabolites, sphingosine-1-phosphate (S1P), cholesterol and derivatives, and other lipid factors such as gangliosides. Promiscuous and selective lipid-sensing are apparent. In many cases the lipids stimulate channel function or increase insertion of channels in the membrane. Both direct and indirect (receptor-dependent) lipid effects are evident. Although information is limited, the lipid profiles are consistent with TRPCs having close working relationships with phospholipase C and A2 enzymes. We need much more information about lipid-sensing by TRPCs if we are to fully appreciate its significance, but the available data suggest that lipid-sensing is a key, but not exclusive, aspect of TRPC biology.


Assuntos
Lipídeos/fisiologia , Canais de Potencial de Receptor Transitório/metabolismo , Ácido Araquidônico/metabolismo , Cálcio/metabolismo , Colesterol/metabolismo , Diglicerídeos/metabolismo , Lisofosfolipídeos/metabolismo , Transdução de Sinais , Esfingosina/análogos & derivados , Esfingosina/metabolismo
4.
Nat Protoc ; 4(2): 244-55, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19197268

RESUMO

Robotic multiwell planar patch-clamp has become common in drug development and safety programs because it enables efficient and systematic testing of compounds against ion channels during voltage-clamp. It has not, however, been adopted significantly in other important areas of ion channel research, where conventional patch-clamp remains the favored method. Here, we show the wider potential of the multiwell approach with the ability for efficient intracellular solution exchange, describing protocols and success rates for recording from a range of native and primary mammalian cells derived from blood vessels, arthritic joints and the immune and central nervous systems. The protocol involves preparing a suspension of single cells to be dispensed robotically into 4-8 microfluidic chambers each containing a glass chip with a small aperture. Under automated control, giga-seals and whole-cell access are achieved followed by preprogrammed routines of voltage paradigms and fast extracellular or intracellular solution exchange. Recording from 48 chambers usually takes 1-6 h depending on the experimental design and yields 16-33 cell recordings.


Assuntos
Dispositivos Lab-On-A-Chip , Técnicas de Patch-Clamp/instrumentação , Robótica/instrumentação , Animais , Astrócitos/fisiologia , Células Cultivadas , Humanos , Linfócitos/fisiologia , Miócitos de Músculo Liso/fisiologia , Técnicas de Patch-Clamp/métodos , Ratos , Robótica/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA